General Information of Drug Off-Target (DOT) (ID: OTEXJ9SL)

DOT Name Forkhead box protein H1 (FOXH1)
Synonyms Forkhead activin signal transducer 1; Fast-1; hFAST-1; Forkhead activin signal transducer 2; Fast-2
Gene Name FOXH1
Related Disease
Clear cell renal carcinoma ( )
Colorectal carcinoma ( )
Friedreich ataxia 1 ( )
Head and neck cancer ( )
Head and neck carcinoma ( )
Myeloid leukaemia ( )
Renal cell carcinoma ( )
Transposition of the great arteries ( )
Ventricular septal defect ( )
Tetralogy of fallot ( )
Congenital heart malformation ( )
Holoprosencephaly ( )
UniProt ID
FOXH1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
5XOC; 7YZB
Pfam ID
PF00250
Sequence
MGPCSGSRLGPPEAESPSQPPKRRKKRYLRHDKPPYTYLAMIALVIQAAPSRRLKLAQII
RQVQAVFPFFREDYEGWKDSIRHNLSSNRCFRKVPKDPAKPQAKGNFWAVDVSLIPAEAL
RLQNTALCRRWQNGGARGAFAKDLGPYVLHGRPYRPPSPPPPPSEGFSIKSLLGGSGEGA
PWPGLAPQSSPVPAGTGNSGEEAVPTPPLPSSERPLWPLCPLPGPTRVEGETVQGGAIGP
STLSPEPRAWPLHLLQGTAVPGGRSSGGHRASLWGQLPTSYLPIYTPNVVMPLAPPPTSC
PQCPSTSPAYWGVAPETRGPPGLLCDLDALFQGVPPNKSIYDVWVSHPRDLAAPGPGWLL
SWCSL
Function
Transcriptional activator. Recognizes and binds to the DNA sequence 5'-TGT[GT][GT]ATT-3'. Required for induction of the goosecoid (GSC) promoter by TGF-beta or activin signaling. Forms a transcriptionally active complex containing FOXH1/SMAD2/SMAD4 on a site on the GSC promoter called TARE (TGF-beta/activin response element).
Tissue Specificity Ubiquitous.
Reactome Pathway
Signaling by Activin (R-HSA-1502540 )
Germ layer formation at gastrulation (R-HSA-9754189 )
Formation of axial mesoderm (R-HSA-9796292 )
Signaling by NODAL (R-HSA-1181150 )

Molecular Interaction Atlas (MIA) of This DOT

12 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Clear cell renal carcinoma DISBXRFJ Strong Altered Expression [1]
Colorectal carcinoma DIS5PYL0 Strong Biomarker [2]
Friedreich ataxia 1 DIS285GE Strong Biomarker [3]
Head and neck cancer DISBPSQZ Strong Genetic Variation [4]
Head and neck carcinoma DISOU1DS Strong Genetic Variation [4]
Myeloid leukaemia DISMN944 Strong Biomarker [5]
Renal cell carcinoma DISQZ2X8 Strong Altered Expression [1]
Transposition of the great arteries DISPXJ8X Strong Biomarker [6]
Ventricular septal defect DISICO41 Strong Genetic Variation [7]
Tetralogy of fallot DISMHFNW moderate Biomarker [8]
Congenital heart malformation DIS7LR56 Limited Unknown [9]
Holoprosencephaly DISR35EC Limited Biomarker [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Forkhead box protein H1 (FOXH1). [11]
------------------------------------------------------------------------------------
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Triclosan DMZUR4N Approved Triclosan decreases the expression of Forkhead box protein H1 (FOXH1). [12]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Forkhead box protein H1 (FOXH1). [13]
Panobinostat DM58WKG Approved Panobinostat increases the expression of Forkhead box protein H1 (FOXH1). [14]
Ethanol DMDRQZU Approved Ethanol increases the expression of Forkhead box protein H1 (FOXH1). [15]
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of Forkhead box protein H1 (FOXH1). [14]
Belinostat DM6OC53 Phase 2 Belinostat increases the expression of Forkhead box protein H1 (FOXH1). [14]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Forkhead box protein H1 (FOXH1). [16]
Trichostatin A DM9C8NX Investigative Trichostatin A increases the expression of Forkhead box protein H1 (FOXH1). [17]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)

References

1 Smad4 suppresses the progression of renal cell carcinoma via the activation of forkhead box protein H1.Mol Med Rep. 2015 Apr;11(4):2717-22. doi: 10.3892/mmr.2014.3061. Epub 2014 Dec 8.
2 FAST1 promotes the migration and invasion of colorectal cancer cells.Biochem Biophys Res Commun. 2019 Feb 5;509(2):407-413. doi: 10.1016/j.bbrc.2018.12.122. Epub 2018 Dec 26.
3 FAST-1 antisense RNA epigenetically alters FXN expression.Sci Rep. 2018 Nov 21;8(1):17217. doi: 10.1038/s41598-018-35639-2.
4 The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer.Int J Cancer. 2014 Nov 15;135(10):2424-36. doi: 10.1002/ijc.28885. Epub 2014 Apr 19.
5 A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1.Cancer Discov. 2019 Jul;9(7):962-979. doi: 10.1158/2159-8290.CD-18-1391. Epub 2019 May 8.
6 Mechanism responsible for D-transposition of the great arteries: Is this part of the spectrum of right isomerism?.Congenit Anom (Kyoto). 2016 Sep;56(5):196-202. doi: 10.1111/cga.12176.
7 Forkhead box H1 (FOXH1) sequence variants in ventricular septal defect.Int J Cardiol. 2010 Nov 5;145(1):83-5. doi: 10.1016/j.ijcard.2009.05.030. Epub 2009 Jun 13.
8 Functionally significant, rare transcription factor variants in tetralogy of Fallot.PLoS One. 2014 Aug 5;9(8):e95453. doi: 10.1371/journal.pone.0095453. eCollection 2014.
9 The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
10 Mutational Spectrum in Holoprosencephaly Shows That FGF is a New Major Signaling Pathway.Hum Mutat. 2016 Dec;37(12):1329-1339. doi: 10.1002/humu.23038. Epub 2016 Aug 23.
11 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
12 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
13 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
14 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
15 Chronic ethanol exposure increases goosecoid (GSC) expression in human embryonic carcinoma cell differentiation. J Appl Toxicol. 2014 Jan;34(1):66-75.
16 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
17 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.